You must remember, OWCP already has contracts in place for much of the world to manufacture, distribute and sell the cream. They should see 25% of sales revenue.
I believe the good news is that this product will have benefits in far more than psoriasis. I believe that psoriasis is probably one of the worst skin diseases, lesser diseases or things like sunburn will gain relief from the use of the cream, even if it isn't curative. If psoriasis has a $7 billion annual market, I suspect that if you add in all the others the market will grow to probably $25 to $50 billion. I don't know how much of the market will be ours, but if our product is as effective as I think it could be, revenues will be well into the billions.
As OWCP truly transitions into a biotech, where all new products are being treated as drugs requiring full blown FDA Trials, annual expenses will grow dramatically. Long term I believe the payoff will be huge as drugs purchased by prescription will bring in far more, yet cost patients less as they'll be covered by Insurance. Some drugs may become over the counter products, but if prescribed, they'll cost less for the patient, while generating more for OWCP.
For anyone who doesn't believe me, check the price of a drug like Omeprazole, which is available OTC, then check the price if it's prescribed, and you have insurance that covers it. You'll be amazed at the savings.
Gary
